However, the HER2-HER3 dimer frequency in HER2+ tumours was not consistently higher (Figure 2d), suggesting that HER2 IHC is not a reliable indicator of HER2-HER3 dimerization. The gene discussed is ERBB2; the disease is neoplasm.